Reference

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AsthmaPsoriasisChronic Obstructive Pulmonary DiseaseSickle Cell DiseaseAtrophic VaginitisChronic Gastritis

1050 competitors in Asthma

#DrugCompanyPhaseTrials

1

Reference

RRespirent Pharmaceuticals Co Ltd.

Phase 3

12

Veramyst

GSK

Preclinical

463

Xolair

Roche

Preclinical

254

Singulair

AstraZeneca

Preclinical

175

Nucala

GGlaxo Dba Glaxosmithkline

Preclinical

356

Cinqair

Teva

Preclinical

137

Asmanex

Novartis

Preclinical

58

Celexa

AbbVie

Preclinical

19

Spiriva

Boehringer Ingelheim

Preclinical

810

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8Show 17 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Salmeterol6 trials

A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50

Unknown status·AAmneal Ireland Limited·Phase 3·NCT03562923·1,204 enrolled

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Completed·RRespirent Pharmaceuticals Co Ltd.·Phase 1·NCT03820180·34 enrolled

A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Completed·RRespirent Pharmaceuticals Co Ltd.·Phase 1·NCT04466176·34 enrolled

Show 3 more trials

A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 Inhalation Powder/GSK in Healthy Volunteers

Completed·RRespirent Pharmaceuticals Co Ltd.·Phase 1·NCT03975166·34 enrolled

A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade

Completed·RRespirent Pharmaceuticals Co Ltd.·Phase 1·NCT04124094·36 enrolled

Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Unknown status·RRespirent Pharmaceuticals Co Ltd.·Phase 1·NCT05085587·18 enrolled

Psoriasis3 trials

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Completed·AAlmirall, S.A.·Phase 2·NCT01283698·20 enrolled

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

Completed·AAlmirall, S.A.·Phase 2·NCT01360944·22 enrolled

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Completed·AAlmirall, S.A.·Phase 2·NCT01119339·20 enrolled

MPA2 trials

A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol

Terminated·AAmneal Ireland Limited·Phase 3·NCT03562949·761 enrolled

A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food

Completed·Boehringer Ingelheim·Phase 1·NCT05428436·24 enrolled

Analgesic Efficacy1 trial

Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery

Completed·IInstitut Bergonié·Phase 2·NCT00210132·90 enrolled

TED1 trial

Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study

Completed·RReckitt Benckiser Healthcare (UK) Limited·Phase 1·NCT03167541·18 enrolled

17 more indications

Post-cesarean Pain1 trial

Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine

Withdrawn·—·Phase 4·NCT01211431

Abuse Potential1 trial

To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen

Completed·Sun Pharma Advanced Research Company Limited·Phase 1·NCT03567941·32 enrolled

Atrophic Vaginitis1 trial

A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis

Completed·AAlvogen Pine Brook LLC·Phase 3·NCT02995694·535 enrolled

Chronic Obstructive Pulmonary Disease1 trial

Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population

Completed·AstraZeneca·Phase 2·NCT01425814·87 enrolled

ART1 trial

Partially Replicate Bioequivalence Study of Quetiapine 25 mg in Healthy Volunteers Under Fasting Condition

Completed·FFuture University in Egypt·Phase 1·NCT05235230·32 enrolled

Asthma1 trial

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

Completed·Cipla·Phase 3·NCT02624505·110 enrolled

Chronic Gastritis1 trial

To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients

Completed·Daewon Pharmaceutical Co., Ltd.·Phase 3·NCT03443804·462 enrolled

TACE1 trial

Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route

Unknown status·—·Phase 1·NCT06126042·330 enrolled

Adult Subject1 trial

A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects

Not yet recruiting·TThe Affiliated Hospital of Qingdao University·Phase 1·NCT06753864·32 enrolled

Liposomal Amphotericin B1 trial

Human Bioequivalence Study of Liposomal Amphotericin B for Injection

Active, not recruiting·SSichuan Huiyu Pharmaceutical Co., Ltd·N/A·NCT06983665·42 enrolled

Phase 11 trial

A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects

Completed·GSK·Phase 1·NCT02688387·112 enrolled

Postmenopausal Women1 trial

A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

Completed·DDaré Bioscience, Inc.·Phase 1·NCT05418426·34 enrolled

CHOP1 trial

Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base

Unknown status·AAmneal Ireland Limited·Phase 3·NCT03549897·100 enrolled

COPD1 trial

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

Completed·LLupin Ltd.·Phase 3·NCT03137992·377 enrolled

Pilot Study1 trial

Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets

Completed·LLupin Ltd.·Phase 1·NCT01712568·12 enrolled

Sickle Cell Disease1 trial

CLIMB SCD-121: Exa-cel in Sickle Cell Disease

Active, not recruiting·CRISPR Therapeutics·Phase 3·NCT04746040·44 enrolled

Unspecified7 trials

Pooled Analysis FP_SX_250_50

Completed·RRespirent Pharmaceuticals Co Ltd.··NCT04790838·82 enrolled

A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects

Completed·PPulmatrix Inc.·Phase 1·NCT02671825·42 enrolled

Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.

Completed·Biogen·Phase 1·NCT01632449·80 enrolled

Show 4 more trials

A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers

Completed·Pfizer·Phase 1·NCT00999817·14 enrolled

Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH

Completed·AAurobindo Pharma Ltd·Phase 3·NCT04051710·1,550 enrolled

An Open-Label, Randomized, Single-Dose, Two-Treatment, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence and Tolerability of Xetrane® 4 mg Hard Capsules and Imnovid® 4 mg Hard Capsules in Healthy Male Subjects Under Fasting Conditions

Completed·KKnight Therapeutics (USA) Inc·Phase 1·NCT07694011·34 enrolled

Bioequivalence Study of Two Formulations of a Sitagliptin/Metformin Hydrochloride Extended-Release Tablet in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open-Label, Single-Dose, Crossover Trial

Completed·TThe Affiliated Hospital of Qingdao University·Phase 1·NCT07679711·76 enrolled

Details

Drug Info

Related News